首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1372707

医疗保健市场中的冷等离子体 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按应用（伤口癒合、手术应用和其他医疗应用）、地区和竞争细分

Cold Plasma in Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Application (Wound Healing, Surgical Application and Other Medical Applications), By Region and Competition

出版日期: 2023年10月03日 | 出版商:

TechSci Research | 英文 183 Pages | 商品交期: 2-3个工作天内

价格

简介目录

医疗保健市场中的冷血浆到 2022 年价值为 18.9 亿美元，在预测期内预计将强劲增长，预计到 2028 年复合年增长率 (CAGR) 为 12.14%。

该市场代表了更广泛的医疗保健行业中一个充满活力且快速发展的领域，专注于将冷等离子体技术应用于各种医疗目的。这些应用涵盖伤口癒合、癌症治疗、消毒和皮肤病学。冷等离子体因其非侵入性和非热性质而脱颖而出，使其成为医疗环境中的多功能工具。其刺激组织再生、促进血管生成和消除病原体而不损害健康组织的独特能力引起了医疗保健提供者、研究人员和行业参与者的极大关注。

近年来，这个市场出现了大幅成长，主要是由于糖尿病和癌症等慢性疾病的盛行率不断上升。这些情况需要创新、高效的治疗解决方案，而冷等离子体已被证明是有效的，特别是在伤口护理方面。它在解决具有挑战性的医疗保健需求方面表现出了希望，例如糖尿病溃疡等慢性伤口。

市场概况
预测期	2024-2028
2022 年市场规模	18.9亿美元
2028 年市场规模	37.7亿美元
2023-2028 年复合年增长率	12.14%
成长最快的细分市场	伤口癒合
最大的市场	北美洲

此外，全球对感染控制和病人安全的重视，特别是应对 COVID-19 大流行，加速了冷等离子技术用于灭菌和净化目的的采用。

主要市场驱动因素

慢性病增加

糖尿病和癌症等慢性病的盛行率不断上升，是推动冷等离子体在医疗保健市场成长的关键因素。慢性病已成为全球健康流行病，对医疗保健系统和患者带来沉重负担。冷等离子体技术已成为解决与这些疾病的管理和治疗相关的一些挑战的有前途的解决方案。

冷等离子体在慢性疾病中的主要应用之一是伤口癒合，特别是对于糖尿病患者。糖尿病溃疡通常癒合缓慢且容易出现併发症，是疾病的常见后果。冷等离子刺激细胞增生和血管生成的能力在加速此类慢性伤口的癒合过程中发挥关键作用。透过增强组织再生和降低感染风险，冷血浆疗法为患有糖尿病相关溃疡的患者带来了希望，改善了他们的生活质量，并有可能预防截肢等更严重的併发症。

此外，全球癌症盛行率呈上升趋势，化疗和放疗等传统治疗方式可能具有侵入性且使人衰弱。冷等离子体技术在选择性靶向和破坏癌细胞同时保护健康组织方面显示出了前景。这种方法不仅提高了癌症治疗的有效性，还最大限度地减少了副作用，增强了患者的整体体验。

医疗保健意识不断提高

「医疗保健意识的提高」因素在冷等离子体在医疗保健市场的成长和演变中发挥着至关重要的作用。在过去的几年中，医疗保健提供者和患者的医疗保健意识发生了显着转变，导致人们越来越认识到冷等离子体技术的潜在好处和应用。

首先，医疗保健提供者越来越意识到冷等离子体在各个医疗领域的多样化应用。他们认识到它有可能彻底改变绝育、伤口癒合、癌症治疗、皮肤病学等领域的实践。这种意识的提高促使医疗机构投资于研发、临床试验以及将冷等离子体设备整合到其治疗方案中。因此，冷等离子体技术的采用在医疗保健环境中获得了广泛关注。

其次，由于网路和社群媒体上医疗保健资讯的激增，患者越来越多地了解替代和创新的治疗方案。这导致对非传统、尖端疗法的需求不断增长，这些疗法可以提供更好的结果并改善患者体验。随着患者变得更加主动地管理自己的健康，他们正在寻找提供先进治疗方法的医疗保健提供者，包括基于冷血浆技术的治疗方法。

此外，COVID-19 大流行在提高医疗保健意识方面发挥了重要作用，即感染控制和病人安全的重要性。冷等离子体在快速、安全地对錶面和设备进行消毒方面的有效性在大流行期间变得显而易见，进一步凸显了其相关性，并促使医疗机构考虑采用它。

主要市场挑战

整合到医疗保健工作流程中

医疗保健市场中冷等离子体面临的挑战是将冷等离子体设备整合到现有的医疗保健工作流程中。儘管该技术前景广阔，但将其无缝融入医疗机构的日常工作和实践中却存在一些复杂性。医疗机构按照完善的协议和程序运作，任何新技术的引入都必须与这些工作流程保持一致，以确保效率和有效性。整合的挑战主要围绕着以下几个方面：

首先，医疗机构需要投资必要的基础设施来容纳冷等离子设备。这包括空间分配、电气要求以及冷等离子设备与现有医疗设备和系统的整合等考虑因素。这些变更可能会占用大量资源，并且需要仔细规划。

其次，员工培训至关重要。从护士到技术人员和医生，医疗保健专业人员需要精通操作和维护冷等离子体设备。必须制定和实施培训计划，持续教育对于让医疗保健提供者了解最佳实践至关重要。

第三，新科技的引进可能会扰乱既定的工作流程。医疗机构必须谨慎管理这项转变，以尽量减少对病人照护的干扰。这可能涉及暂时并行的流程或逐步整合以确保平稳转变。

最后，冷等离子技术的整合会带来成本。医疗机构必须为设备采购、员工培训和基础设施改善分配预算。对于一些机构，尤其是规模较小的医疗保健提供者来说，这种财务承诺可能是一个重大障碍。

实施成本

医疗保健市场冷等离子体面临的挑战是实施成本。儘管冷等离子体技术的优势日益受到认可，但其收购、整合和营运所需的初始财务投资可能对医疗保健提供者和机构来说是一个重大障碍。

首先，购买冷等离子体设备的前期成本可能很高。高品质的冷等离子设备是技术先进的精密仪器，通常带有相应的价格标籤。较小的医疗机构或预算有限的机构可能会发现为初始购买分配资源具有挑战性。

其次，除了购置成本之外，还必须考虑持续的营运费用。这包括冷等离子体设备的维护、校准和定期维修，以确保其最佳运作。此外，诸如气体供应等消耗品的成本可能会增加实施的总成本。

此外，可能需要对基础设施和设备进行投资以适应冷等离子体技术。为了满足冷等离子体设备的电气和空间要求而对现有医疗环境进行改造可能会增加财务负担。

医疗保健提供者还必须分配资源用于员工培训和教育。确保医疗保健专业人员熟练使用和维护冷等离子体设备对于安全有效的操作至关重要。

主要市场趋势

数据驱动的医疗保健

医疗保健市场冷等离子体的主要趋势以数据驱动的医疗保健为中心。这一趋势的标誌是冷等离子体设备与先进的资料收集和分析系统的集成，以提高治疗精度和有效性。

在当今的医疗保健领域，资料为王。冷等离子技术也不例外。製造商正在将感测器和监控功能整合到冷等离子体设备中，以便在治疗过程中即时收集资料。此资料可以包括温度、气体流速和处理持续时间等参数。然后收集到的资讯被传输到集中系统或云端平台，在那里可以进行分析和解释。

使用冷血浆进行数据驱动的医疗保健的优势是显着的。它使医疗保健提供者能够根据患者特定资料密切监测和调整治疗，优化治疗结果。例如，在伤口癒合中，数据驱动的系统可以评估组织对冷等离子体治疗的反应，并进行即时调整以促进更快的癒合。在癌症治疗中，可以密切监测治疗效果，确保冷等离子体精确靶向癌细胞，同时保护健康组织。

此外，收集的资料可以有助于研究和开发工作，促进冷等离子体技术及其在医疗保健中的应用的不断改进。它还支持基于证据的决策，这对于获得监管部门的批准和在医疗保健专业人员之间建立信任至关重要。

这一趋势与医疗保健领域更广泛的数位化趋势一致，提供更高的治疗精度、患者安全以及更有效、个人化的医疗护理的潜力。随着数据驱动的方法变得越来越普遍，它们预计将进一步巩固冷等离子体技术作为现代医疗保健实践中有价值的工具的作用。

个人化医疗

在医疗保健市场的背景下，个人化医疗代表了一种变革性的患者护理和治疗方法，可根据个人特征、需求和遗传特征量身定制医疗干预措施。这一趋势正在透过强调医疗保健解决方案交付的精确性和客製化来重塑医疗保健市场中的冷等离子体。在个人化医疗中，治疗和疗法的设计旨在与患者独特的基因组成和病史精确匹配。这种方法可以进行更有针对性和更有效的干预措施，降低不良反应的风险并优化治疗结果。对于医疗保健市场中的冷等离子体，这意味着冷等离子体技术可以微调，以满足每个患者的特定要求，无论是在伤口癒合、癌症治疗或其他应用中。随着患者和医疗保健提供者越来越多地寻求不仅有效、而且能最大限度地减少副作用并最大限度地提高成功可能性的治疗方法，对个人化医疗的需求不断增加。冷等离子体的适应性和多功能性使其非常适合这一趋势，因为它可以根据个别患者的需求进行调整和优化。此外，个人化医疗有潜力推动医疗保健市场冷血浆的研究和发展。随着更多关于患者结果和治疗反应的资料被收集，它可以为冷等离子体技术及其应用的改进提供信息，从而产生更有效、以患者为中心的解决方案。

细分市场洞察

应用洞察

伤口癒合领域在医疗保健市场的冷等离子体中占据主导地位，预计在未来几年将继续扩大。伤口癒合领域在医疗保健市场冷等离子体中的主导地位可归因于几个令人信服的因素，使其成为具有持续扩张前景的领导者。首先，糖尿病性溃疡和压疮等慢性伤口在全球范围内构成了日益严峻的医疗保健挑战。这些情况需要创新且有效的伤口护理解决方案，而冷等离子技术已成为一个有希望的答案。冷等离子体透过刺激细胞增生、血管生成和组织再生来加速伤口癒合，同时最大限度地降低感染风险。这种卓越的治疗能力引起了医疗保健提供者和研究人员的极大关注。其次，随着世界各地的医疗保健系统寻求具有成本效益和高效的解决方案，冷等离子体在伤口护理中的作用越来越突出。透过加快癒合过程并降低併发症的风险，它不仅可以改善患者的治疗效果，而且从长远来看还有助于节省成本。医疗机构越来越认识到使用冷等离子设备的经济效益。此外，COVID-19 大流行凸显了维持无菌医疗环境和高效伤口护理的重要性，进一步扩大了对冷血浆解决方案的需求。医院和诊所寻求有效的感染控制和伤口治疗方法，使冷等离子体技术成为医疗保健领域的重要资产。

区域洞察

北美地区已成为 2022 年冷等离子体医疗市场的领导者。首先，北美拥有强大而完善的医疗基础设施，包括尖端的医疗设施、研究机构和技术先进的医疗保健部门。这为冷血浆等创新技术的采用和整合到主流医疗保健实践中提供了有利的环境。其次，该地区对医疗保健进步和病人安全重要性的认识不断提高，推动了冷等离子体技术的快速采用。北美的医疗保健提供者越来越认识到冷血浆在灭菌、伤口癒合和癌症治疗方面的好处，特别是在 COVID-19 大流行的背景下。这导致对冷等离子体设备的需求激增。第三，北美的监管环境虽然严格，但为医疗技术的批准和部署提供了明确的途径。美国 FDA 等监管机构一直积极参与冷等离子设备的评估和批准，使医疗保健提供者对其安全性和有效性充满信心。此外，北美学术界、工业界和医疗保健提供者之间的合作促进了创新和知识共享，促进了冷等离子体技术在不同医学专业的开发和实施。

This market represents a dynamic and rapidly evolving sector within the broader healthcare industry, focused on applying cold plasma technology for various medical purposes. These applications span wound healing, cancer treatment, sterilization, and dermatology. Cold plasma stands out due to its non-invasive and non-thermal nature, making it a versatile tool in medical settings. Its unique ability to stimulate tissue regeneration, promote angiogenesis, and eradicate pathogens without harming healthy tissues has garnered significant attention from healthcare providers, researchers, and industry players.

Recent years have witnessed substantial growth in this market, primarily driven by the increasing prevalence of chronic diseases like diabetes and cancer. These conditions demand innovative and efficient treatment solutions, and cold plasma has proven effective, particularly in wound care. It has shown promise in addressing challenging healthcare needs, such as chronic wounds like diabetic ulcers.

Market Overview
Forecast Period	2024-2028
Market Size 2022	USD 1.89 Billion
Market Size 2028	USD 3.77 Billion
CAGR 2023-2028	12.14%
Fastest Growing Segment	Wound Healing
Largest Market	North America

Furthermore, the global emphasis on infection control and patient safety, particularly in response to the COVID-19 pandemic, has accelerated the adoption of cold plasma technology for sterilization and decontamination purposes.

The Cold Plasma in Healthcare market also benefits from collaborative research efforts involving academia, industry, and healthcare providers. These collaborations facilitate innovation and knowledge sharing. As the market continues to expand, it is expected to encompass a broader range of medical specialties, offering personalized and precision treatments. With regulatory support, ongoing technological advancements, and increasing healthcare awareness, cold plasma technology is poised to play an increasingly pivotal role in improving patient outcomes and safety. This makes it an exciting and promising sector for stakeholders and investors in the healthcare arena.

Key Market Drivers

Increasing Chronic Diseases

The increasing prevalence of chronic diseases, such as diabetes and cancer, is a pivotal factor driving the growth of the Cold Plasma in Healthcare market. Chronic diseases have become a global health epidemic, imposing significant burdens on healthcare systems and patients alike. Cold plasma technology has emerged as a promising solution to address some of the challenges associated with the management and treatment of these conditions.

One of the primary applications of cold plasma in the context of chronic diseases is in wound healing, particularly for individuals with diabetes. Diabetic ulcers, often slow to heal and prone to complications, are a common consequence of the disease. Cold plasma's ability to stimulate cell proliferation and angiogenesis plays a critical role in expediting the healing process for such chronic wounds. By enhancing tissue regeneration and reducing infection risk, cold plasma therapy offers hope to individuals suffering from diabetes-related ulcers, improving their quality of life and potentially preventing more severe complications like limb amputations.

Moreover, the prevalence of cancer is on the rise globally, and traditional treatment modalities like chemotherapy and radiation therapy can be invasive and debilitating. Cold plasma technology has shown promise in the selective targeting and destruction of cancer cells while sparing healthy tissue. This approach not only improves the effectiveness of cancer treatment but also minimizes side effects, enhancing the overall patient experience.

Rising Healthcare Awareness

The factor of "Rising Healthcare Awareness" plays a crucial role in the growth and evolution of the Cold Plasma in the Healthcare market. Over the past few years, there has been a notable shift in healthcare awareness among both healthcare providers and patients, leading to increased recognition of the potential benefits and applications of cold plasma technology.

Firstly, healthcare providers are becoming more aware of the diverse applications of cold plasma in various medical fields. They are recognizing its potential to revolutionize practices in sterilization, wound healing, cancer treatment, dermatology, and beyond. This heightened awareness has prompted healthcare institutions to invest in research and development, clinical trials, and the integration of cold plasma devices into their treatment protocols. As a result, the adoption of cold plasma technology has gained traction within healthcare settings.

Secondly, patients are increasingly informed about alternative and innovative treatment options, thanks to the proliferation of healthcare information through the internet and social media. This has led to a growing demand for non-traditional, cutting-edge therapies that offer better outcomes and improved patient experiences. As patients become more proactive in managing their health, they are seeking out healthcare providers who offer advanced treatments, including those based on cold plasma technology.

Additionally, the COVID-19 pandemic played a significant role in raising healthcare awareness regarding the importance of infection control and patient safety. Cold plasma's effectiveness in quickly and safely sterilizing surfaces and equipment became evident during the pandemic, further highlighting its relevance and prompting healthcare facilities to consider its adoption.

Key Market Challenges

Integration into Healthcare Workflows

Challenge facing the Cold Plasma in Healthcare market is the integration of cold plasma devices into existing healthcare workflows. While the technology holds immense promise, seamlessly incorporating it into the routines and practices of healthcare facilities presents several complexities. Healthcare institutions operate within well-established protocols and procedures, and any introduction of new technology must align with these workflows to ensure efficiency and effectiveness. The challenges of integration primarily revolve around the following aspects:

Firstly, healthcare facilities need to invest in the necessary infrastructure to accommodate cold plasma devices. This includes considerations such as space allocation, electrical requirements, and the integration of cold plasma equipment with existing medical equipment and systems. These changes can be resource-intensive and require careful planning.

Secondly, staff training is paramount. Healthcare professionals, from nurses to technicians and physicians, need to be proficient in operating and maintaining cold plasma devices. Training programs must be developed and implemented, and ongoing education is essential to keep healthcare providers updated on best practices.

Thirdly, the introduction of new technology can disrupt established workflows. Healthcare institutions must carefully manage this transition to minimize disruptions to patient care. This may involve temporarily parallel processes or gradual integration to ensure a smooth shift.

Lastly, there is a cost associated with the integration of cold plasma technology. Healthcare facilities must allocate budgets for equipment acquisition, staff training, and infrastructure improvements. This financial commitment can be a significant hurdle for some institutions, particularly smaller healthcare providers.

Cost of Implementation

Challenge in the Cold Plasma in Healthcare market is the cost of implementation. While the benefits of cold plasma technology are increasingly recognized, the initial financial investment required for its acquisition, integration, and operation can be a significant barrier for healthcare providers and institutions.

Firstly, the upfront cost of purchasing cold plasma equipment can be substantial. High-quality cold plasma devices are precision instruments with advanced technology, which often comes with a corresponding price tag. Smaller healthcare facilities or those with limited budgets may find it challenging to allocate resources for the initial purchase.

Secondly, beyond the acquisition cost, ongoing operational expenses must be considered. This includes maintenance, calibration, and regular servicing of the cold plasma devices to ensure they function optimally. Additionally, the cost of consumables, such as gas supplies, may add to the overall cost of implementation.

Furthermore, investments in infrastructure and facilities may be necessary to accommodate cold plasma technology. Modifications to existing healthcare environments to meet the electrical and spatial requirements of cold plasma equipment can contribute to the financial burden.

Healthcare providers must also allocate resources for staff training and education. Ensuring that healthcare professionals are proficient in using and maintaining cold plasma devices is essential for safe and effective operation.

Key Market Trends

Data-Driven Healthcare

Key trend in the Cold Plasma in Healthcare market centers around data-driven healthcare. This trend is marked by the integration of cold plasma devices with advanced data collection and analysis systems to enhance treatment precision and effectiveness.

In today's healthcare landscape, data is king. Cold plasma technology is no exception. Manufacturers are incorporating sensors and monitoring capabilities into cold plasma devices, allowing for real-time data collection during treatments. This data can include parameters like temperature, gas flow rates, and treatment duration. The information collected is then transmitted to centralized systems or cloud platforms, where it can be analyzed and interpreted.

The advantages of data-driven healthcare with cold plasma are significant. It enables healthcare providers to closely monitor and adjust treatments based on patient-specific data, optimizing therapeutic outcomes. For example, in wound healing, data-driven systems can assess tissue response to cold plasma treatment and make real-time adjustments to promote faster healing. In cancer treatment, treatment efficacy can be closely monitored, ensuring that the cold plasma precisely targets cancer cells while sparing healthy tissue.

Furthermore, the collected data can contribute to research and development efforts, facilitating continuous improvement in cold plasma technology and its applications in healthcare. It also supports evidence-based decision-making, which is crucial for gaining regulatory approvals and building trust among healthcare professionals.

This trend aligns with the broader movement toward digitalization in healthcare, offering increased treatment precision, patient safety, and the potential for more effective, personalized medical care. As data-driven approaches become more prevalent, they are expected to further solidify the role of cold plasma technology as a valuable tool in modern healthcare practices.

Personalized Medicine

Personalized medicine, within the context of the healthcare market, represents a transformative approach to patient care and treatment that tailors medical interventions to individual characteristics, needs, and genetic profiles. This trend is reshaping the Cold Plasma in Healthcare market by emphasizing precision and customization in the delivery of healthcare solutions. In personalized medicine, treatments and therapies are designed to align precisely with a patient's unique genetic makeup and medical history. This approach allows for more targeted and effective interventions, reducing the risk of adverse effects and optimizing therapeutic outcomes. For the Cold Plasma in Healthcare market, this means that cold plasma technology can be fine-tuned to suit the specific requirements of each patient, whether it's in wound healing, cancer treatment, or other applications. The demand for personalized medicine is on the rise as patients and healthcare providers increasingly seek treatments that are not only effective but also minimize side effects and maximize the likelihood of success. Cold plasma's adaptability and versatility make it well-suited to this trend, as it can be adjusted and optimized for individual patient needs. Furthermore, personalized medicine has the potential to drive research and development in the Cold Plasma in Healthcare market. As more data is collected on patient outcomes and treatment responses, it can inform the refinement of cold plasma technologies and their applications, resulting in more effective and patient-centric solutions.

Segmental Insights

Application Insights

The Wound Healing Segment dominates the Cold Plasma in Healthcare market and is predicted to continue expanding over the coming years. The dominance of the Wound Healing Segment in the Cold Plasma in Healthcare market can be attributed to several compelling factors, making it a frontrunner with continued expansion prospects. Firstly, chronic wounds, such as diabetic ulcers and pressure sores, pose a growing healthcare challenge globally. These conditions demand innovative and effective wound care solutions, and cold plasma technology has emerged as a promising answer. Cold plasma accelerates wound healing by stimulating cell proliferation, angiogenesis, and tissue regeneration while minimizing infection risk. This exceptional therapeutic capacity has garnered significant attention from healthcare providers and researchers. Secondly, as healthcare systems worldwide seek cost-effective and efficient solutions, the role of cold plasma in wound care gains prominence. By expediting the healing process and reducing the risk of complications, it not only improves patient outcomes but also contributes to cost savings in the long run. Healthcare institutions are increasingly recognizing the economic benefits of implementing cold plasma devices. Moreover, the COVID-19 pandemic underscored the importance of maintaining sterile healthcare environments and efficient wound care, further amplifying the demand for cold plasma solutions. Hospitals and clinics sought effective means of infection control and wound treatment, making cold plasma technology a critical asset in the healthcare landscape.

Regional Insights

The North America region has established itself as the leader in the Cold Plasma in Healthcare Market in 2022. Firstly, North America boasts a robust and well-established healthcare infrastructure, which includes cutting-edge medical facilities, research institutions, and a technologically advanced healthcare sector. This provides a conducive environment for the adoption and integration of innovative technologies like cold plasma into mainstream healthcare practices. Secondly, the region's heightened awareness of healthcare advancements and the importance of patient safety has driven the rapid adoption of cold plasma technology. Healthcare providers in North America are increasingly recognizing the benefits of cold plasma in sterilization, wound healing, and cancer treatment, particularly in the context of the COVID-19 pandemic. This has led to a surge in demand for cold plasma devices. Thirdly, North America's regulatory environment, while stringent, provides clear pathways for the approval and deployment of medical technologies. Regulatory agencies like the FDA in the United States have been actively engaged in assessing and approving cold plasma devices, giving healthcare providers confidence in their safety and efficacy. Moreover, collaborations between academia, industry, and healthcare providers in North America have fostered innovation and knowledge sharing, facilitating the development and implementation of cold plasma technology in diverse medical specialties.

Key Market Players

Neoplas med GmbH

U.S. Medical Innovations

Terumo Medical Corp

Adtec Plasma Technology Co Ltd

Apyx Medical Corp

Nordson Corp

Europlasma NV

Terraplasma GmbH

Henniker Plasma

Smith & Nephew plc

Report Scope:

In this report, the Cold Plasma in Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cold Plasma in Healthcare Market, Application:

Wound Healing
Surgical Application
Other Medical Applications

Cold Plasma in Healthcare Market, By Region:

North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
Italy
France
Spain
Asia Pacific
China
India
Japan
South Korea
Australia
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Cold Plasma in Healthcare Market.

Available Customizations:

Cold Plasma in Healthcare Market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cold Plasma in Healthcare Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Application (Wound Healing, Surgical Application and Other Medical Applications)
- 5.2.2. By Region
- 5.2.3. By Company (2022)
5.3. Market Map

6. North America Cold Plasma in Healthcare Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Application
- 6.2.2. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Cold Plasma in Healthcare Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Application
- 6.3.2. Canada Cold Plasma in Healthcare Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Application
- 6.3.3. Mexico Cold Plasma in Healthcare Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Application

7. Europe Cold Plasma in Healthcare Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Application
- 7.2.2. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Cold Plasma in Healthcare Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Application
- 7.3.2. United Kingdom Cold Plasma in Healthcare Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Application
- 7.3.3. Italy Cold Plasma in Healthcare Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecasty
    - 7.3.3.2.1. By Application
- 7.3.4. France Cold Plasma in Healthcare Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Application
- 7.3.5. Spain Cold Plasma in Healthcare Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Application

8. Asia-Pacific Cold Plasma in Healthcare Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Application
- 8.2.2. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Cold Plasma in Healthcare Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Application
- 8.3.2. India Cold Plasma in Healthcare Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Application
- 8.3.3. Japan Cold Plasma in Healthcare Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Application
- 8.3.4. South Korea Cold Plasma in Healthcare Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Application
- 8.3.5. Australia Cold Plasma in Healthcare Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Application

9. South America Cold Plasma in Healthcare Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Application
- 9.2.2. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Cold Plasma in Healthcare Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Application
- 9.3.2. Argentina Cold Plasma in Healthcare Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Application
- 9.3.3. Colombia Cold Plasma in Healthcare Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Application

10. Middle East and Africa Cold Plasma in Healthcare Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Application
- 10.2.2. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Cold Plasma in Healthcare Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Application
- 10.3.2. Saudi Arabia Cold Plasma in Healthcare Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Application
- 10.3.3. UAE Cold Plasma in Healthcare Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development
12.2. Mergers & Acquisitions

13. Global Cold Plasma in Healthcare Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Treatment Types

15. Competitive Landscape

15.1. Business Overview
15.2. Service Offerings
15.3. Recent Developments
15.4. Key Personnel
15.5. SWOT Analysis
- 15.5.1. Neoplas med GmbH
- 15.5.2. U.S. Medical Innovations
- 15.5.3. Terumo Medical Corp
- 15.5.4. Adtec Plasma Technology Co Ltd
- 15.5.5. Apyx Medical Corp
- 15.5.6. Nordson Corp
- 15.5.7. Europlasma NV
- 15.5.8. Terraplasma GmbH
- 15.5.9. Henniker Plasma
- 15.5.10. Smith & Nephew plc

16. Strategic Recommendations

17. About Us & Disclaimer

02-2729-4219

+886-2-2729-4219

License/价格

医疗保健市场中的冷等离子体 - 2018-2028 年全球行业规模、份额、趋势、机会和预测，按应用（伤口癒合、手术应用和其他医疗应用）、地区和竞争细分

Cold Plasma in Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Application (Wound Healing, Surgical Application and Other Medical Applications), By Region and Competition

主要市场驱动因素

慢性病增加

医疗保健意识不断提高

主要市场挑战

整合到医疗保健工作流程中

实施成本

主要市场趋势

数据驱动的医疗保健

个人化医疗

细分市场洞察

应用洞察

区域洞察

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：客户之声

第 5 章：全球冷等离子体在医疗保健市场的前景

第 6 章：北美冷等离子体在医疗保健市场的前景

第 7 章：欧洲冷等离子体在医疗保健市场的前景

第 8 章：亚太冷等离子体在医疗保健市场的前景

第 9 章：南美洲冷等离子体在医疗保健市场的前景

第 10 章：中东和非洲冷等离子体医疗保健市场前景

第 11 章：市场动态

第 12 章：市场趋势与发展

第 13 章：医疗保健市场中的全球冷等离子：SWOT 分析

第 14 章：波特的五力分析

第15章：竞争格局

第 16 章：策略建议

第 17 章：关于我们与免责声明

Key Market Drivers

Increasing Chronic Diseases

Rising Healthcare Awareness

Key Market Challenges

Integration into Healthcare Workflows

Cost of Implementation

Key Market Trends

Data-Driven Healthcare

Personalized Medicine

Segmental Insights

Application Insights

Regional Insights

Key Market Players

Report Scope:

Cold Plasma in Healthcare Market, Application:

Cold Plasma in Healthcare Market, By Region:

Competitive Landscape

Available Customizations:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Cold Plasma in Healthcare Market Outlook

6. North America Cold Plasma in Healthcare Market Outlook

7. Europe Cold Plasma in Healthcare Market Outlook

8. Asia-Pacific Cold Plasma in Healthcare Market Outlook

9. South America Cold Plasma in Healthcare Market Outlook

10. Middle East and Africa Cold Plasma in Healthcare Market Outlook

11. Market Dynamics

12. Market Trends & Developments

13. Global Cold Plasma in Healthcare Market: SWOT Analysis

14. Porter's Five Forces Analysis

15. Competitive Landscape

16. Strategic Recommendations

17. About Us & Disclaimer